| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 8 Feb 2025 | 28 Jan 2025 |
| Godavari Biorefineries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve the Unaudited Financial Results of the Company on Standalone and Consolidated basis for the quarter and nine months ended on December 31 2024. We wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. 8% February, 2025 has inter-alia Considered and approved Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine months ended 31st December, 2024, as reviewed and recommended by the Audit Committee. In this regard, we are enclosing herewith Un- Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Nine months ended 31st December, 2024 along with the Limited Review Report issued by the Statutory Auditors of the Company. (As Per Bse Announcement Dated on 08.02.2025) | ||
| Board Meeting | 18 Nov 2024 | 12 Nov 2024 |
| Godavari Biorefineries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/11/2024 inter alia to consider and approve to consider and approve unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended 30th September 2024 We wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. 18th November, 2024 has inter-alia Considered and approved Un-Audited Financial Results (standalone and consolidated) of the company for the quarter and half year ended 30th September, 2024, as reviewed and recommended by the Audit Committee. In this regard, we are enclosing herewith Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Half year ended 30th September 2024 along with the Limited Review Report issued by the Statutory Auditors of the Company (As per BSE Announcement Dated on 18/11/2024) | ||
The ethanol and bio-based chemicals manufacturer raised ₹554.75 crore through its public offering
A minimum of 42 shares and their multiples are available for investors to apply for.
The IPO includes a fresh issue of ₹325 Crore and an offer-for-sale of 6.52 million shares.
Of the 31,45,977 shares set aside for qualified institutional buyers (QIBs), they had only placed bids for 8,526 shares.
The IPO comprises a fresh equity issue worth ₹325 Crore and an Offer for Sale (OFS) of 65.27 lakh shares, valued at ₹230 Crore, leading to a total IPO size of ₹555 Crore.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
